Allstate Corp Alnylam Pharmaceuticals, Inc. Transaction History

Allstate Corp

$1.02 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$185.53 - $241.31 $14,471 - $18,822	78 Added 1.51%	5,228 $1.24 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $49,597 - $83,056	358 Added 7.47%	5,150 $1.03 Million
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $395,579 - $556,117	-3,285 Reduced 40.67%	4,792 $699,000
Q1 2022 May 16, 2022	SELL	$127.18 - $173.91 $353,814 - $483,817	-2,782 Reduced 25.62%	8,077 $1.32 Million
Q4 2021 Feb 15, 2022	BUY	$159.56 - $209.29 $875,984 - $1.15 Million	5,490 Added 102.25%	10,859 $1.84 Million
Q3 2021 Nov 15, 2021	SELL	$169.75 - $207.73 $75,538 - $92,439	-445 Reduced 7.65%	5,369 $1.01 Million
Q2 2021 Aug 16, 2021	SELL	$128.63 - $176.89 $48,236 - $66,333	-375 Reduced 6.06%	5,814 $986,000
Q1 2021 May 14, 2021	BUY	$126.83 - $175.69 $123,405 - $170,946	973 Added 18.65%	6,189 $874,000
Q4 2020 Feb 12, 2021	SELL	$122.97 - $147.0 $35,169 - $42,042	-286 Reduced 5.2%	5,216 $678,000
Q3 2020 Nov 13, 2020	SELL	$121.19 - $165.49 $19,148 - $26,147	-158 Reduced 2.79%	5,502 $801,000
Q2 2020 Aug 13, 2020	SELL	$104.21 - $156.44 $111,296 - $167,077	-1,068 Reduced 15.87%	5,660 $838,000
Q1 2020 May 15, 2020	SELL	$93.12 - $133.99 $772,523 - $1.11 Million	-8,296 Reduced 55.22%	6,728 $732,000
Q3 2019 Nov 14, 2019	BUY	$70.9 - $87.82 $800,461 - $991,487	11,290 Added 302.36%	15,024 $1.21 Million
Q2 2019 Aug 14, 2019	SELL	$65.86 - $92.79 $204,561 - $288,205	-3,106 Reduced 45.41%	3,734 $271,000
Q1 2019 May 20, 2019	BUY	$72.76 - $93.45 $2,401 - $3,083	33 Added 0.48%	6,840 $639,000
Q4 2018 Feb 13, 2019	BUY	$62.67 - $88.33 $426,594 - $601,262	6,807 New	6,807 $496,000

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

Capital World Investors Los Angeles, CA

16.5M
Shares

$4.19 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$3.21 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.42 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.33 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.26 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.

Account